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Abstract
The recent increasing interest in the use of different nanoparticles in biological and medi-
cal applications encouraged scientists to analyse their potential impact on biological 
systems. The biocompatibility analyses of novel materials for medical applications are 
conducted using quantitative and qualitative techniques collected by the International 
Standards Organization (ISO). The well-known assays, such as tetrazolium-based assays 
used for mitochondrial function monitoring, LDH for membrane permeability determina-
tion and neutral red uptake (NRU) describing lysosome function, need to be optimised 
due to specific properties of wide range of nanomaterials. Physicochemical properties 
of nanoparticles (NPs) such as size, composition, concentration, shape and surface (e.g., 
charge, coating, aspect ratio), as well as the cell type play a crucial role in determining the 
nanomaterial toxicity (also uptake pathway(s) of NPs). Different nanomaterials exhibit 
different cytotoxicity from relatively non-toxic hexagonal boron nitride to rutile TiO
2
 NPs 
that induce oxidative DNA damage in the absence of UV light. Finally, the results of 
the nanomedical analysis can be enriched by holographic microscopy that gives valuable 
information about the doubling time (DT), cell segmentation, track cell movement and 
changes in cell morphology. The results can be also completed by phenotype microarrays 
(PMs) and atomic force microscopy (AFM) techniques that fulfil experimental data.
Keywords: general cytotoxicity, nanomaterials, AFM analysis, holographic analysis, 
phenotype microarrays
1. Introduction
This chapter is dedicated to selected methods used to analyse the biocompatibility/cytotoxicity of 
different nanomaterials. The effect of nanomaterials on cellular metabolism and relative viability 
can differ according to their properties and experimental design. As shown by Frewin et al. [1], 
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biocompatibility analyses of novel materials for medical applications are conducted using quan-
titative and qualitative techniques. These techniques have been collected by the International 
Standards Organization (ISO) 10,9931 (ISO-10993-1, 2009; ISO-10993-5, 2009; ISO-10993-6, 2007).
Nanotechnology and nanobiotechnology have focused scientists’ attention in the last few 
years on their application in biomedical research, such as detecting and monitoring systems 
of cells within the body, delivery systems for various drugs, hyperthermia treatment, photo-
dynamic therapy and tissue engineering [2]. The term ‘nano’ may be considered a different 
state of aggregation of matter in all its states—solid, liquid, gas and plasma [3].
The phenomenon of nanoparticles is based on their different physical (optical and electromag-
netic), chemical (catalytic) and mechanical properties that depend on particle size, as well as sur-
face and quantum effects. The surface effects manifest as scaling of physical properties (increased 
atomic fraction on particle surface compared to the interior), which includes increased chemical 
reactivity and reduced melting point of nanoparticles compared to larger particles of bulk mate-
rial. NPs have a very large surface area in comparison to microparticles and larger materials, 
making this large surface area available for chemical reactions [4]. In addition, nanoparticles can 
be classified according to their composition (inorganic and organic, lipid-based and polymeric 
NPs), dimensionality, morphology, uniformity and agglomeration [Table 1] [3, 5]. Another clas-
sification divides nanomaterials into three groups: zero-dimensional materials (quantum dots), 
varying in shape and diameter; one-dimensional materials (nanorods and nanowires) and two-
dimensional materials (nanobelts, nanodisks and nanosheets) [2].
The toxicity and cytotoxicity of nanomaterials are complex and depend on various factors, such 
as chemical composition, crystalline structure, size (at the nanolevel, the basic physicochemi-
cal properties of materials can change with variation in size) or aggregation. Nanomaterial 
composition determines its chemical interaction with cells, cellular uptake mechanisms and 
intracellular localisation. Chemical composition may also induce oxidative stress. For exam-
ple, silver nanoparticle aggregates are more toxic than asbestos; CNTs are highly toxic and 
evoke much more damaging effect to the lungs than carbon black or silica NPs, but titanium 
oxide, iron oxide and zirconium oxide NPs are less toxic than asbestos [3, 6].
The crystalline structure effect of NP toxicity causes that some nanomaterials with a specific 
crystalline structure do not exhibit high toxicity, but other allotropes can strongly affect cell 
viability and exert an effect on human organism. Sato and co-workers [7] demonstrated that 
TiO
2
 allotropes exhibited different toxicity. Rutile TiO
2
 NPs (200 nm) induced oxidative DNA 
damage in the absence of UV light and also TiO
2
 NPs (10–20 nm) stimulated reactive oxygen 
species (ROS) production under corresponding conditions; in contrast, anatase NPs of the 
same size did not cause this effect [3, 8, 9].
Another factor that determines nanomaterial toxicity is the size of NPs. In most cases, smaller 
nanoparticles are able to pass through physiological barriers. Small-size nanoparticles can 
1ISO-10993 ISO-10993-1 (ISO-10993-1 (2009) - Biological evaluation of medical devices — Part 1: Evaluation and testing 
within a risk management process; ISO-10993-5 (2009) - Biological evaluation of medical devices — Part 5: Tests for 
in vitro cytotoxicity; ISO-10993-6 (2007) – Biological evaluation of medical devices — Part 6: Tests for local effects after 
implantation
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enter cells by phagocytosis and other mechanisms (e.g., micropinocytosis, receptor-mediated 
endocytosis (RME) pathways mediated by caveolae, clathrin and caveolae/clathrin-indepen-
dent endocytosis) [10, 11]. NP ability to enter the cells determines adhesive interactions, such 
as van der Waals forces, steric interactions or electrostatic charges [3, 12, 13]. Moreover, NPs 
smaller than 100 nm are not phagocytized as opposed to larger nanoparticles, but they enter 
via RME pathways [2, 11]. NP uptake can also occur in the absence of specific cell surface recep-
tors. Nanoparticles smaller than 50 nm can easily enter most cells (with greater cytotoxicity), 
Classes Types Structure Size Properties
Carbon-based 
nanoparticles
Carbon nanotubes 
(CNTs)
Single-walled CNT 
(SWCNTs)
Multi-walled CNT 
(MWCNTs)
Diameter 
between 0.4 and 
100 nm; length 
between several 
nanometres up 
to centimetres
Improved compressive 
strength, tensile bending 
strength, flexural strength, 
durability, piezoelectric 
response, sensing ability
Graphene (GF) and 
graphene oxide (GO)
Hydrophobic two-
dimensional single 
monoatomic layers 
(GF)
Oxidised form of  
GF (GO)
From 0.1 up to 
300 μm
Large area; its surface can be 
easily functionalized with 
functional groups; ideal for 
high drug loading via π-π 
stacking, hydrophobic or 
electrostatic interactions; 
exceptional mechanical 
properties
Nanodiamonds  
(ND)
Truncated octahedral 
structure
Diameter 
between 2 and 
10 nm
Large area, enhanced 
biocompatibility, good 
mechanical strength, surface 
functionality, colloidal 
stability
Inorganic 
nanoparticles
Gold nanoparticles 
(GNPs, AuNPs)
Colloidal gold, 
nanorods, nanowires
Sizes of 
1–100 nm
Absorb and scatter light; 
catalyst applications; 
anti-fungal, anti-microbial 
properties
Silver nanoparticles 
(AgNPs)
Colloidal silver, 
spherical silver 
nanoparticles, 
diamond, octagonal, 
thin sheets
Diameter 
between 1 and 
100 nm in size
Significant anti-microbial 
properties
Iron oxide 
nanoparticles  
(IONPs)
Magnetite (Fe3O4); oxidised form 
maghemite (γ-Fe
2
O3)
Sizes of 1 and 
100 nm
Superparamagnetic 
properties; the surface 
area-to-volume ratio is 
significantly high; higher 
binding capacity and 
excellent dispersibility
Mesoporous 
nanoparticles 
(MSN, MSNPs)
Nanosilica Solid material with 
a porous, hexagonal, 
cubic and cage type
50–300 nm Porous structure and large 
surface area; chemical 
stability; surface functionality 
and biocompatibility
Table 1. Types of nanomaterials [3, 5, 7].
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while nanoscale devices smaller than 20 nm can cross blood vessels and cumulate in tissues [2]. 
Particles with larger surface area display tendency to agglomerate in the liquid, interact with 
molecules, such as proteins and DNA and may cause oxidation and DNA damage [3, 4, 14].
It is known that the shape (aspect ratio) also determines cellular uptake efficiency and may 
affect cell viability. Additionally, surface chemistry of nanomaterials modulates the response 
of biological systems and distribution in the organism. Surface functionalisation (with Fe3O4, gold nanoparticles; type of bonding on the surface, e.g., covalent, noncovalent; dispersing 
agents, e.g., PEG) is a crucial factor that can significantly change the toxicity of NPs and pre-
vent NPs from aggregating; it can also change their fate in biological systems [2, 3, 11]. For 
example, functionalization of MWCNTs with sodium sulfonic acid salt (─SO3Na or -phenyl-
SO3Na) increased their biocompatibility in comparison with unfunctionalised or carboxylic acid–functionalized (─COOH) MWCNTs [15]. Cellular uptake depends on different factors, 
such as nanomaterial and cell type, but also on environmental properties and the complexity of 
culture media. These specific conditions determine the aggregation process, which makes the 
interpretation of data on nanoparticle biodistribution or uptake difficult [3]. NP agglomerates 
affect and limit the direct extrapolation of in vitro data (providing a basis for understanding the 
mechanism of NP cytotoxicity and their uptake at the cellular level) to in vivo exposure [11, 16].
Intercellular localization of NPs and their interaction with cell components, such as the mem-
brane, mitochondria, lysosomes and/or nucleus, are essential [11]. NPs can affect cell and organ-
elle membranes, induce oxidative stress (ROS), DNA damage and mutagenesis and evoke 
apoptosis and protein up-/downregulation [11]; they can also modulate immune response [3, 17].
2. Nanoparticle cytotoxicity analyses and their limitations
The cytotoxicity study is an essential and crucial step in testing novel substances/nanomateri-
als in the context of biological and medical applications. Assays based on tetrazolium salts, 
like MTT (2-(4,5-dimethyl-2-thiazolyl)-3,5-diphenyl-2H-tetrazolium bromide), nitroblue tet-
razolium (NBT) and the second-generation tetrazolium salts, such as XTT (sodium 2,3-bis(2-
methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)-carbonyl]-2H-tetrazolium inner salt), MTS 
(5-[3-(carboxymethoxy)phenyl]-3-(4,5-dimethyl-2-thiazolyl)-2-(4-sulfophenyl)-2H-tetrazo-
lium inner salt) and WST-1 (sodium 5-(2,4-disulfophenyl)-2-(4-iodophenyl)-3-(4-nitrophenyl)-
2H-tetrazolium inner salt) are basic tools for cytotoxicity determination, but nanomaterial 
testing is associated with certain challenges. The type of nanomaterials, manufacturing condi-
tions, colloidal dispersion, chemical purity and photocatalytic activity of NPs may determine 
the usage of most traditional assays. Interactions between nanoparticles and molecules (i.e., 
reactants) used in well-established assays significantly affect the results and are one of the 
reasons of result variations [18, 19]. In assays based on colorimetric and fluorescence measure-
ments, it has been found that nanomaterials, such as carbon nanotubes (CNTs), graphene/
graphene oxide nanosheets, TiO
2
 nanoparticles or boron nitride, interact with chromophore 
molecules, which may lead to false-positive results [19–21]. In other cases, the total surface 
area of NPs was sufficient to adsorb the reagent or fluorescent molecules, especially those 
with aromatic rings, which in turn led to false-negative results [21]. These results suggest 
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using alternative cytotoxicity assays based on tetrazolium salts, e.g., XTT, WST-1, INT or other 
assays that complement the analysis, e.g., Alamar Blue (AB), neutral red uptake (NRU) assay, 
LDH leakage assay, flow cytometry, cell death analysis (using trypan blue or annexin V/prop-
idium iodide), protein concentration measurements using the Bradford assay, measurements 
of mitochondrial membrane permeability (MMP) or loss of glutathione (e.g., GSH) and the 
activation of proinflammatory cytokines (e.g., IL-6, IL-8 and/or TNF-α) [15, 19, 21].
A number of studies have been carried out to verify the effect of NPs on assay reagents [22]. 
Wörle-Knirsch and co-workers [23] indicated that CNT analysed using the MTT assay caused 
false-positive results due to the strong interaction between CNT and the insoluble formazan 
crystals [19, 23]. In the aforementioned study, SWCNTs were analysed on A549 (human alveo-
lar epithelial cell line), ECV304 (endothelial cells derived from umbilical cord) and NR8383 
(rat alveolar macrophage cell line) cell cultures and the results obtained in the MTT assay 
were verified by WST-1, LDH, mitochondrial membrane potential (MMP) and annexin V/PI 
analysis. The MTT assay indicated that SWCNTs affected cell viability, reducing it almost by 
60% after a 24-h incubation period. Moreover, the decreased cell viability did not recover after 
longer incubation or higher concentrations of nanotubes. The results of the MTT assay were 
verified using WST-1, and no reduction in viability was detected. LDH and MMP assays con-
firmed WST-1 results, and flow cytometry using annexin V/propidium iodide showed lack of 
necrosis and/or apoptosis. Wörle-Knirsch et al. [23] concluded that nanotoxicological assays 
needed standardising with regard to the tested nanomaterial
Lupu and Popescu [24] used the MTT assay to evaluate TiO
2
 toxicity. The effect of TiO
2
 
nanoparticles on living models is crucial due to their utilisation in food, beauty care and phar-
macology industries. Additionally, TiO
2
 nanoparticles are known to exhibit photocatalytic 
properties: the ability to catalyse redox reactions of molecules adsorbed on the surface dur-
ing light exposition (λ < 385 nm). Photocatalytic reaction may occur by direct charge transfer 
of electrons (e−) and holes (h+) generated by light on the surface of titania nanoparticles. The 
reaction may be also mediated by reactive oxygen species (ROS), e.g., hydroxyl radicals (˙OH) or superoxide anions (˙O2−) formed at the interface of TiO2 and water. Lupu and Popescu [24] clearly demonstrated that TiO
2
 nanoparticles induced transformation of noncellular MTT to 
formazan. Formazan formation was found to be proportional to titania NPs, and this process 
was enhanced by daylight exposure. Moreover, the results obtained in the experiment without 
cellular model were validated using three cell lines—V79-4, HeLa and B16. The results dem-
onstrated false viability that increased up to 14% for TiO
2
 concentrations higher than 50 μgml−1 
[24]. In addition, the TiO
2
-MTT reaction was analysed in PBS environment. The reaction rate 
(formazan production rate) was proportional to TiO
2
 and UV radiations (at 312 and 365 nm 
wavelengths) and inversely proportional to initial concentration of MTT. Moreover, reaction 
efficiency was enhanced by the presence of Na
2
HPO
4
 (phosphate concentration of 0.005 M for 
maximum efficiency), which is the basic component of PBS [25].
Casey et al. [26, 27] proved that single-walled carbon nanotubes (HiPco®) interacted with 
indicator dyes applied in Coomassie Blue, AlamarBlue™, neutral red uptake, MTT and 
WST-1 assays. In all cases, nanotubes interacted with dyes, which resulted in the reduction 
of the associated absorption/fluorescent emission. A spectroscopic study demonstrated that 
SWCNTs interacted with Coomassie and reduced the absorbance for all concentrations tested 
General Cytotoxicity and Its Application in Nanomaterial Analysis
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(0.003–0.800 mgml−1). As regards the AlamarBlue™ analysis (fluorescent measurements of all 
single-walled carbon nanotube solutions), quenching was monitored as a function of SWCNT 
concentration and plotted as an emission ratio at 595 nm by 540 nm excitation for the AB assay 
(5% solution of AB in culture medium) against SWCNT concentration. Another assay measur-
ing NR uptake also showed SWCNT’s ability to quench NR emission and was described as a 
function of SWCNT concentration. The MTT assay used in the cited study was found to inter-
act with CNT. The reduction in MTT was associated with SWCNT concentration (absorption 
reduction was higher with increasing SWCNT concentration). For the WST-1 assay, it was 
concluded that the reduction in WST-1 absorbance was dependent on nanotube concentra-
tions above 0.0125 mgml−1. Casey et al. concluded that Coomassie, AB, NRU, MTT and WST-1 
assays were not appropriate for the cytotoxicity analysis of carbon nanotubes [26, 27].
Limitations of MTT in cytotoxicity studies on graphene and graphene-related materials have been 
demonstrated in numerous publications. CCK-8 (tetrazolium-8-[2-(2-methoxy-4-nitrophenyl)-
3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium] monosodium salt) assays are an attrac-
tive alternative for the MTT test. Evaluation of graphene adsorption was based on cell-free 
adsorptive experiments and demonstrated a gradual reduction of MTT to 93% during 2-h incu-
bation, whereas CCK-8 was significantly reduced to 73% after exposure to graphene for 2 h. The 
intensity of graphene adsorption to MTT and CCK-8 was time-dependent. The quantity of the 
CCK-8 reagent absorbed by graphene was higher than that of MTT. It was reported that the π-π 
conjugated system of the CCK-8 molecule was much stronger than that of MTT due to three 
benzene rings and one five-membered heterocycle. MTT contains only two benzene rings and 
two five-membered heterocycles. Another reason for that process is that benzene ring groups 
strongly affect the adsorption. It was also noted that graphene can suppress the fluorescence 
effect caused by electron transfer from the dye molecule to the graphene surface. Although MTT 
and CCK-8 reagents are not fluorescent dyes, both of them display a positive electron on the 
molecules, similar to some known fluorescent dyes. Thus, it is possible that electron transfer 
occurs during the incubation with graphene and interferes with the dye molecule that contacts 
the enzymes. Jiao et al. noted that CCK-8 molecules can be more significantly disturbed by gra-
phene than by the MTT reagent. Additionally, optical properties of graphene may also result in 
the loss of light signals used for detection in assays in vitro [28].
Cytotoxicity can also be determined using the lactate dehydrogenase (LDH) assay. The LDH 
assay is performed to exclude interactions between nanomaterials and fluorophore molecules 
[19]. The LDH assay, similar to the MTT assay, is a colorimetric method; thus, it can also 
interact with nanoparticles (e.g., CNT). Formazan crystals can be absorbed on the surface 
of MWNT (multi-walled nanotubes) through a strong π-π stacking interaction. The analysis 
of Ali-Boucetta et al. [19] proved that media containing the released LDH showed the same 
absorbance (at 490 nm) as MWNT:F127 (multi-walled nanotubes dispersed in the presence of 
Pluronic 127) dispersion in culture media. Ali-Boucetta et al. [19] proposed LDH assay modi-
fication that would eliminate the potential risk of interference of assay components with NPs 
(modified method vs. traditional procedure is presented in Figure 1).
In the experiment of Han et al. [29], copper (Cu-40), silver (Ag-35 and Ag-40) and titanium diox-
ide (TiO
2
-25) were used to validate the popular assay. It was found that LDH was inactivated in 
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the presence of Cu-40 and AG-35 in a dose-dependent manner. The effect of TiO
2
-25 and Ag-40 
NPs was not significant. In conclusion, these authors underlined the necessity to interpret the 
results with caution because of metal-catalysed oxidation [29].
Wang et al. [30] proposed modifying the LDH assay that would correct the erroneous results 
caused by potential interference of nanotubes with reporter chromophore, resulting in its 
adsorption on nanoparticle surface. The idea of this modification is based on the incubation of 
LDH derived from a known number of cells (e.g., DH82 macrophage cells) or a purified LDH 
standard (lactic dehydrogenase enzyme purified from rabbit muscle) with a precise amount (at 
different concentrations ranging from 5 to 100 μgml−1) of SWCNT or SWCNT-ox (carbon nano-
horns). This additional procedure enables the quantification of the effects of NPs on the LDH 
level. The results obtained by Wang and co-workers clearly demonstrated that LDH concentra-
tions decreased with increasing CNT concentration (at a wavelength of 490 nm). On the other 
hand, the 580 nm peak was elevated at the increased maximum absorbing wavelength. Based 
on the observation and regression analyses performed by Wang et al. [30], it was suggested that 
Figure 1. Schematic of the original (A) and modified LDH assay (B) [19].
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LDH assay results should be verified by calibration curves in the presence of different SWCNT 
concentrations (in the range of 5–100 μgml−1) at two wavelengths, 580 and 490 nm, for each 
LDH assay. This procedure more accurately determines cellular toxicity values [30].
Smith et al. [31] presented a simple protocol modification of the LDH analysis, which 
included membered additional conditional-specific controls. This modification enables accu-
rate simultaneous measurement of the effects of death and growth inhibition. The additional 
step provides quantitative information that can be useful in applications such as drug discov-
eries [31]. Another approach in LDH assay analysis was proposed in the experiments of Chan 
et al. [32]. Modification of the LDH protocol allows to detect necrosis, including secondary 
necrosis [32].
In addition, calcein AM (CAM), Live/Death, neutral red, CellTiter®, Aqueous One (96 AQ), 
Alamar Blue (AB), CellTiter-Blue® (CTB), CytoToxOne™, and flow cytometry were used to 
determine their utility in nanoparticle toxicity evaluation. In the cited study, it was found that the 
results of the assay that depended on direct staining of cells were difficult to interpret, because 
of dye interactions with NPs. The 96 AQ assay proved optimal for NP analysis. The results were 
not significantly altered by interactions between the test factor and reagents in the assay [16].
Herzog et al. [33] suggested the clonogenic assay to determine real cytotoxic effect on cell cul-
tures due to the false results (positive or negative) that may occur in NP testing. The clonogenic 
assay (colony formation assay) is based on the ability of a single cell to form a colony. The lat-
ter study was based on the ability of A549, BEAS-2B (normal human bronchial epithelial cells) 
and HaCaT (normal human keratinocytes) cells to form colonies after 7 (for HaCaT cells) and 
10 (for A549 and BEAS-2B) days of incubation with SWCNT (HiPco®). The EC50 comparison showed that the A549 cell line was more resistant than the other two lines. On the other hand, 
the analysis based on colony size showed that A549 was more sensitive than HaCaT cells. 
Although the clonogenic assay provided more accurate results than colorimetric tests, it did 
not become popular because it was too time-consuming for rapid toxicity screening [19, 33].
3. Difficulties in nanomaterial cytotoxicity analysis: Aggregates, 
protein corona and NP degradation
Nanomaterials are intensively studied as promising candidates for biomedical applications 
(e.g., targeted delivery of therapeutic drugs and medical imaging) with a purpose of even-
tual human administration [34]. NP design for medical applications should not only meet 
requirements, such as biocompatibility and biodegradability, but also site-specific delivery, 
long blood circulation and high cargo loading capacity [35]. Different nanomaterials show 
unique physical and chemical properties that depend, among others, on the type of materials 
(e.g., Au or Ag, Fe3O4, graphene and graphene oxide), hydrodynamic size, surface charge and aggregation behaviour and have been found to interact, often immediately (within seconds), 
after contact with biological systems, such as blood or tissue [34, 36, 37]. Nanoparticle aggre-
gation via electrostatic screening can occur in complex aqueous mixtures of cell culture media 
that contain electrolytes, proteins, lipids and metabolites (highly ionic environment) [11, 38].
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NPs at higher concentrations tend to form aggregates (agglomerates) under artificial condi-
tions of in vitro cell cultures [16]. Many experiments found that NPs that form aggregates 
were not as cytotoxic as the same NPs at lower concentrations. Lower concentrations of NPs 
resulted in better internalisation and biodistribution in the circulatory system and organs 
[3]. Aggregation process is caused by magnetic attraction forces (types 1, 2 and 4), hydro-
phobic-hydrophobic interactions (for type 1) or hydrogen bonding between hydroxyl groups 
[39]. Different types of nanomaterials exhibit different tendency to form aggregates in PBS 
and culture media. CNTs have a strong tendency to agglomerate due to van der Waals inter-
actions [40]. Metal oxides display higher tendency to form agglomerates in comparison to 
MWCNT. Metal oxides differ in size but were of similar size in PBS environment; thus, it 
was concluded that surface chemistry and/or the environment had a more significant effect 
on the aggregate formation process [14]. The size of aggregates may be dependent on the 
concentration and they tend to be slightly larger in culture media than in PBS. Moreover, 
monovalent and divalent cations may affect aggregate formation. Adsorption of media com-
ponents, serum proteins and Ca2+ on nanoparticle surface determines NP aggregations and 
size distribution [14]. Agglomeration leads to cytotoxicity reduction, because of lower avail-
ability of inorganic NPs in contact with cells. In addition, the size of aggregates prevents their 
cellular internalisation [39]. Studies based on silica nanoparticles indicated that minimization 
of NP aggregation could be obtained by introducing an optimum balance of inert (e.g., methyl 
phosphonate) and active (e.g., hydroxyl and aldehyde) functional groups to the surface [41].
The protein layer of several nanometres on particle surface is called protein corona and it 
can be divided into a peripheral soft corona (SC)—dynamic protein exchanges with the sur-
rounding medium—and a hard corona (HC)—a layer of more or less temporal constant com-
position (Figure 2, Table 2) [34, 42, 43]. In blood plasma, the surface of nanoparticles mainly 
adsorbs proteins, but some minor traces of lipids have also been found in the corona struc-
ture. Adsorption of proteins on the nanoparticle surface is the result of protein-nanoparticle 
binding affinities and protein-protein interactions. Hard corona interacts directly with the 
nanomaterial surface. Soft corona proteins interact with the hard corona via weak protein-
protein interactions. Interestingly, the corona on the NP surface does not completely mask 
the nanomaterial surface or its functional groups [43]. The formation of protein corona and its 
thickness is a parameter that is also dependent on protein concentration, temperature, dura-
tion of particle-protein interaction, serum concentration and shear stress [34, 44].
Protein corona formation strongly affects cellular uptake mechanism, cell-nanoparticle interac-
tions, intracellular location as well as cellular response (e.g., biocompatibility) [34, 35, 44]. The 
protein corona on the NP surface is hypothesised to hinder interactions of nanoparticle ligands 
and the targets on the cell surface [44, 47].
The study of Mirshafiee et al. [44] found that the protein corona formed on BCN-NPs (NPs 
functionalized with bicyclononyne) incubated in medium with 10% serum and 100% serum 
consisted of abundant proteins, such as chain A, a novel allosteric mechanism in haemoglo-
bin, fetuin, haemoglobin foetal subunit beta or apolipoprotein A-II precursor. It was also 
reported that ≥88% of proteins in BCN-NP coronas had a molecular weight below 30 kDa. 
Even relatively low molecular weight proteins created corona that significantly reduced NP 
General Cytotoxicity and Its Application in Nanomaterial Analysis
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targeting efficiency [44]. Single-walled carbon nanotubes (HiPco®) were also found to interact 
with cell culture medium and its components. Casey et al. described that SWCNT interacted 
with the medium via physisorption through van der Waals forces [26, 48].
The process of protein corona formation has a decisive influence on nanoparticle-induced 
toxicity. For example, silica nanoparticles (AmSil30) precoated with human plasma caused 
lower cell-death induction in primary human endothelial cells and microvascular endothelial 
cell line (ISO-HAS1). The resulting effect was dependent on the time of corona formation. 
The most significant effect was recorded for the early corona, but prolonged incubation with 
plasma (>30 min) did not counteract membered toxicity [49]. In another example, thrombo-
cytes were used to study the protein corona effect on the biological model. In the latter study, 
nanoparticles exposed to human plasma for 0.5 min did not activate thrombocytes to form 
aggregates due to the presence of the plasma protein corona [49]. The impact of protein corona 
formation on cellular uptake and dispersion state of nanoparticles after exposure to plasma 
was also investigated. It was found that NPs were monodispersed after short-time exposure 
(<10 min), whereas aggregates started to form during prolonged exposure (>30 min), but the 
Figure 2. Structure of protein corona [34, 42, 43, 45].
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tendency to form aggregates was mostly dependent on physicochemical properties of NPs. 
However, Tenzer et al. [49] did not describe negative effects of AmSil30 precoated with the 
protein plasma corona. Biological effects of protein-NPs were analysed using two lines: HeLa 
and U937 [43, 50]. The study conducted by Maiorano et al. [50] demonstrated that AuNPs 
incubated in two different culture media (DMEM and RPMI) exhibited different protein coro-
nas. RPMI-treated NPs had less prominent protein coronas and, as a consequence, induced 
stronger toxicity of HeLa and U937 cells [50]. The study of Gräfe et al. [34] reported that the 
presence of the protein corona reduced the interaction of human brain microvascular endo-
thelial cells (HBMEC) with magnetic nanoparticles coated with PEI (polyethylenimine) dur-
ing 30 min of incubation [34].
Nanoparticle-induced pathological effects, such as cell death, coagulation, thrombocytosis or 
cytotoxicity, are also dependent on the type of NPs, but selected cellular model is also crucial 
in this kind of experiments [49, 51]. For example, polystyrene-based NPs (PS) with different 
PS-COOH and PS-PO3 groups coated with the serum protein were effectively taken up by both exposed cell lines (HeLa and hMSCs). NPs with PS-NH
2
 and PS-SO3 groups showed lower uptake by both cell lines [51].
The composition of protein corona was analysed using various methods and it was demon-
strated that albumin, immunoglobulin G (IgG), fibrinogen and apolipoproteins were present in 
Hard corona Soft corona
Tightly bound proteins Loosely bound proteins
Large binding energy adsorption (↑|ΔG
ads
|) Low binding energy adsorption (↓|ΔG
ads
|)
Lower dissociation rate of proteins with nanoparticles 
(↓koff)
Higher dissociation rate of proteins with nanoparticles 
(↑koff)
Directly interacting with surface of nanoparticles Protein-protein interaction
Stable on nanoparticle surface; able to influence the 
functional response
Fleeting on nanoparticles; irrelevant for the functional 
response
Table 2. Characteristic features of hard (HC) and soft corona (SC) [46].
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the corona of all the analysed nanoparticles [43]. Corona identification and composition analy-
sis (Table 3) provide not only information about its complexity, conditions of PC formation and 
physicochemical features but also data on toxicity, cellular interactions and uptake, targeting 
and finally the usefulness in nanomedicine [46].
For example, Urbas et al. [52] demonstrated that three types of nanoparticles, NPs-GO, Fe3O4, 
and GO-Fe3O4, displayed the ability to deplete various quantities of serum proteins from cul-ture media (Figure 3). Graphene oxide and nanocomposite GO-Fe3O4 showed an increase in protein adsorption from culture medium. The results of the bicinchoninic acid (BCA) assay 
indicated different capacities of NPs to adsorb proteins in cell cultures [52].
Protein corona composition is also known to affect nanoparticle-cell interactions and biological 
fate of nanomaterials in cells. Gunawan and co-authors characterised the term ‘biological fate’ as 
describing the subcellular localisation of NPs and the distribution of NPs to specific organs in vivo 
[53]. An interesting study performed by Lesniak et al. [54] showed that silica (SiO
2
) nanoparticles 
(50 nm) exposed to biological fluids (e.g., serum) mediated the interaction of NPs (at 100 μgmL−1 
concentration) with A549 cells. Silica nanoparticles showed different degree and process of inter-
nalisation during incubation with the A549 cell line in complete (with 10% foetal bovine serum) 
and in serum-free medium. NP integration was higher in serum-free medium with accumulation 
in lysosomes and some of NPs localised free in the cytosol. On the contrary, NPs in complete 
medium (in the presence of a well-developed corona) were never observed free in the cytoplas-
mic matrix, but similar to serum-free medium, silica nanoparticles were found to accumulate 
in lysosomes. Lesniak et al. [54] observed that nanoparticles showed higher tendency to adhere 
to the cell membrane in serum-free conditions and concluded that the initial stronger adhesion 
could have partly contributed to higher uptake efficiency. Moreover, the presence of free NPs 
in the cytosol might be caused by perturbation of the early uptake pathway in cells exposed to 
serum-free medium (rather than an endogenously regulated cellular process) [53, 54].
Other results described various biological responses of different cell types to NPs with protein 
corona layers [53]. Single-walled carbon nanotubes preferentially bound IgM relative to IgG 
Feature Techniques for PC analysis
Isolation of NPs-PC Centrifugation, size exclusion chromatography (SEC), magnetic separation/
magnetic flow field fractionation (MgFFF)
PC structure analysis Dynamic light scattering (DLS), differential centrifugal sedimentation (DCS), 
transmission electron microscopy (TEM)
Protein quantitation Bicinchoninic acid (BCA) assay, Bradford assay, thermogravimetric analysis 
(TGA)
Binding affinity/stoichiometry and 
protein interaction
Fluorescence correlation spectroscopy (FCS), size exclusion chromatography 
(SEC), isothermal titration calorimetry (ITC), surface plasmon resonance 
(SPR), quartz crystal microbalance (QCM), Z-potential measurement, in silico 
simulation
PC composition One-dimensional gel electrophoresis (1-DE or SDS-PAGE), two-dimensional 
gel electrophoresis (2-DE), mass spectrometry (MS)
Table 3. Analytical methods for corona evaluation [46].
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on PEG-SWCNTs due to the surface charge and the conformation of surface functional groups 
(PEG); this resulted in higher accumulation of the aforementioned NPs in the liver compared 
to the spleen [55]. Poly(D,L-lactide)-based NPs showed interaction of surface functional 
group (covalently conjugated with apoB100 antibody) with LDL and were highly accumulated by liver macrophages [56]. Solid lipid nanoparticles (SLNs) modified with PEG induced the 
ABC phenomenon (accelerated blood clearance) upon repeated injections in mice and beagles. 
Moreover, PEGylated SLNs promoted liver/spleen uptake of NPs [57].
The application of polyethyleneglycol (PEG) for nanoparticle modifications reduces (but not 
totally suppresses) nonspecific protein corona formation [35, 51]. On the other hand, zwitterionic 
NPs were described to lack the protein corona [51].
The use of different nanomaterials for biomedical applications is indispensably associated 
with wide physico-chemical and biocompatibility analyses. The analysis of the effect of nano-
materials on different types of cells in various experimental conditions is an essential step 
in assessing the response of biological models (in vitro and/or in vivo) to direct contact with 
NPs [2]. On the other hand, cells/cell culture conditions as well as living system/biological 
fluids also affect morphological and physico-chemical properties of nanomaterials. Interesting 
results were obtained in the degradation process of sandwich-like mesoporous silica flake 
(mSiO
2
) nanomaterial (developed as anticancer drug system) exposed to PSB solution for 24, 
48 and 96 h. TEM analysis of mSiO
2
 [Figure 4] showed that the porous structure of nanomate-
rial was degraded already after 24-h incubation in PBS [Figure 4a]. Another deformation found 
in mSiO
2
 flake analysis was visible as large holes [Figure 4b-d]. The intensity of mesoporous 
silica flake degradation was time-dependent—the degree of deformation was associated with 
the size of holes formed in the nanoflake structure. The appearance of shapeless silica agglom-
erates was an additional result of the degradation process. Ninety-six-hour incubation caused 
deformation holes in silica nanoflakes that reached the point of total destruction of NPs [58].
Evidence of nanostructure biodegradation of the sandwich-like mesoporous silica flakes has 
also been confirmed in another study. After 48-h incubation, the whole surface of silica nano-
flakes was covered with cavities and was entirely destroyed [59]. The mechanism of silica 
dissolution is based on two simultaneous processes—degradation and re-deposition of silica 
Figure 3. Protein adsorption onto tested NPs after 48-h incubation period in complete cell growth medium [52].
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on nanoparticle surface. Moreover, the effect of “self-healing” defects between both Si─O─Si 
bonds of double-linked Si atoms explains the very low rate of dissolution at the point of zero 
net proton charge (PZPC) of the surface [60].
A similar effect of PSB incubation on mesoporous silica nanospheres was observed by Yamada 
and co-workers [61], as these authors found that the mSiO
2
 porous structure was degradable 
after 2-day incubation in PBS. After 3-day incubation, mSiO
2
 displayed size and shape degra-
dation with the final shape deformation and collapse of structures [61]. Another study based 
on core-shell magnetic mesoporous silica nanoparticles presented comparable results. Silica 
mesoporous hollow shells immersed in PBS for 2 days displayed structure deformation and 
additional cavities, whereas 8-day incubation showed complete degradation and coagula-
tion resulting in new structure formation [62]. The erosion of mesoporous silica nanosphere 
structure modified with titanium dioxide was also observed in contact with Streptomyces cells. 
After 24-h incubation, mesoporous silica shell structure was degraded with simultaneous 
appearance of agglomerates, which clearly demonstrated that nanomaterial structure and 
composition could be affected by living cells [63].
4. Novel approaches in cytotoxicity studies
4.1. Phenotype arrays
Phenotype is the effect exerted by molecules (e.g., drugs, nanoparticles, etc.) on a cell, tissue or 
whole organism; thus, the phenotype screening provides a holistic analysis that usually is more 
Figure 4. Transmission electron microscopy of mSiO
2
 (‘contr’ – control sample) and mSiO
2
 incubated in PBS, for 24 (a), 
48 (b) and 96 h (c, d) [58].
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comprehensive than the sum of its parts. “Phenomics” is a part of complex technologies that 
also include transcriptomics, proteomics and metabolomics. PMs give a possibility to screen 
thousands of cellular phenotypes in real time [64].
Phenotype MicroArrays™ (PMs) are a combination of microplate reader (that can measure OD 
every 1 min over few hours and provide information about kinetics of carbon energy reactions 
in a selected cell model) and microscopic modules equipped with fluorescence, brightfield, 
colour brightfield and phase contrast microscopy (for scanning changes in cell morphology 
during experiments). Phenotypic assays deliver more information and provide better under-
standing of the metabolic and cytotoxic effect of test substances [65]. Multiplex arrays can 
generate information on the use of energy pathways (based on the application of different 
nutrition analyses, PM-M1 to M4), effects of ions (PM-M5), hormones, metabolic effectors 
(PM-M6 to M8) and anti-cancer agents (PM-M11 to M14) (Table 4), cell number, cell health 
(based on cell health monitoring using phase contrast microscopy and kinetic determination 
of cellular energy) and apoptotic induction (via cell subpopulation analysis—examination of 
the increase in circularity due to cell shrinkage and cytoplasm condensation and lower phase 
signal exhibition) [65]. PMs can be used in genotype/phenotype analyses, cell line characterisa-
tion, metabolic reprogramming, cellular phenotype stability, Warburg effect, cell differentia-
tion or bioprocess development [64]. Well-characterised model cell lines (e.g., HepG2, C3A, 
Colo205, A549, PC-3, IMR90, HL-60 or CEM) with defined metabolic properties can be used 
with the PM system to determine specific effects of nanomaterials on selected cell lines and to 
accurately identify the mechanism involved in the NP effect (e.g., mitochondrial toxicology) 
on the living system [66]. Array wells coated with different substances and combined with the 
redox assay (MA or MB redox dyes to measure cell energy [NADH] changes) are used for phe-
notypic determination. Comparison of two cell lines is visualised by bioinformatic software 
that highlights differences in recorded phenotypes (Figure 5) [64, 67].
For example, Phenotype MicroArrays™ (PM-M TOX1 Plate Energetic Substrate Assay, 96-well 
microplate coated with eight different oxidisable carbon sources—each of the eight nutrition 
sources coated on one of eight rows on a microplate) give the possibility to screen cell-based 
energetic phenotype in a target cell model, for example, the MDA-MB-231 RFP breast can-
cer cell line, using different cellular nutrition sources (e.g., α-D-glucose, inosine, D-galactose, 
D-glucose-1-phosphate, xylitol, α-ketoglutaric acid, D,L-β-hydroxybutyric acid or pyruvic 
acid). This kind of multiplex analysis provides information on cell morphology, metabolic 
activity (metabolic pathway activity), sensitivity in response to particular energetic additives 
and the final cellular genetic background characterisation. The addition of an apoptotic agent 
(e.g., oridonin), chemical inhibitor or stimulator provides an opportunity to evaluate the poten-
tial mechanism regulating the energy pathway [65, 66]. Another example of PM application 
was presented by Bochner et al. [68]. Based on four phenotypic assays (PM-M1 to M4, contain-
ing 367 substrate nutrients), different human cancer cell lines, including HepG2/C3A, HepG2, 
Colo 205, A549, PC-3, HL-60 and CCRF-CEM and two murine white and brown adipocyte cell 
lines were analysed to determine energy-producing pathways. The results showed that human 
cancer cell lines exhibited distinct metabolic activity profiles. Moreover, white and brown adi-
pocyte cell lines also had different profiles of energetic activity; metabolic fingerprints were 
established in all cell lines [68]. Similarly, human endothelial cells from the coronary artery 
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Phenotype 
MicroArrays™
Feature Substrates/agents
PM-M TOX1 (Biolog) Effect of a tested factor 
on energy production 
(mitochondrial toxicity)
Eight different carbon source: α-D-glucose, inosine, 
D-galactose, D-glucose-1-phosphate, xylitol, 
α-ketoglutaric acid, D,L-β-hydroxybutyric acid, pyruvic 
acid
PM-M1 (Biolog) Energetic substrate array Carbon and energy sources (simple sugars, 
polysaccharides, carboxylic acids): cyclodextrin, 
dextrin, glycogen, maltitol, maltotriose, D-maltose, 
D-trehalose, D-cellobiose, gentiobiose, D-glucose-6-
phosphate, D-glucose-1-phosphate, L-glucose, D-glucose, 
3-O-methyl-D-glucose, methyl-D-glucoside, D-salicin, 
D-sorbitol, N-acetyl-D-glucosamine, D-glucosaminic 
acid, D-glucuronic acid, chondroitin-6-sulphate, mannan, 
D-mannose, methyl-D-mannoside, D-mannitol, N-acetyl-
β-D-mannosamine, D-melezitose, sucrose, palatinose, 
D-turanose, D-tagatose, L-sorbose, L-rhamnose, L-fucose, 
D-fucose, D-fructose-6-phosphate, D-fructose, stachyose, 
D-raffinose, D-lactitol, lactulose, α-D-lactose, melibionic 
acid, D-melibiose, D-galactose, α-methyl-D-galactoside, 
N-acetyl-neuraminic acid, pectin, sedoheptulosan, 
thymidine, uridine, adenosine, inosine, adonitol, 
L-arabinose, D-arabinose, β-methyl-D-xylopyranoside, 
xylitol, myo-inositol, meso-erythritol, propylene glycol, 
ethanolamine D,L- α-glycerol-phosphate, glycerol, citric 
acid, tricarballylic acid, D,L-lactic acid, methyl D-lactate, 
methyl pyruvate, pyruvic acid, α-keto-glutaric acid, 
succinamic acid, succinic acid, mono-methyl succinate, 
tricarballylic acid, L-malic acid, D-malic acid, meso-
tartaric acid, acetoacetic acid (a), γ-amino-N-butyric acid, 
α-keto-butyric acid, α-hydroxy-butyric acid, D,L-β-
hydroxy-butyric acid, γ-hydroxy-butyric acid, butyric 
acid, 2,3-butanediol, 3-hydroxy-2-butanone, propionic 
acid, acetic acid, hexanoic acid
PM-M2 (Biolog) Energetic substrate array Carbon and energy sources/nitrogen sources (protein-
derived nutrients, primarily amino acids, dipeptides): 
Tween 20, Tween 40, Tween 80, gelatin, L-alaninamide, 
L-alanine, D-alanine, L-arginine, L-asparagine, L-aspartic 
acid, D-aspartic acid, L-glutamic acid, D-glutamic acid, 
L-glutamine, glycine, L-histidine, L-homoserine, hydroxy-
L-proline, L-isoleucine, L-leucine, L-lysine, L-methionine, 
L-ornithine, L-phenylalanine, L-proline, L-serine, 
D-serine, L-threonine, D-threonine, L-tryptophan, 
L-tyrosine, L-valine, Ala-Ala, Ala-Arg, Ala-Asn, Ala-Asp, 
Ala-Glu, Ala-Gln, Ala-Gly, Ala-His, Ala-Ile, Ala-Leu, 
Ala-Lys, Ala-Met, Ala-Phe, Ala-Pro, Ala-Ser, Ala-Thr, 
Ala-Trp, Ala-Tyr, Ala-Val, Arg-Ala (b), Arg-Arg (b), 
Arg-Asp, Arg-Gln, Arg-Glu, Arg-Ile (b), Arg-Leu (b), 
Arg-Lys (b), Arg-Met (b), Arg-Phe (b), Arg-Ser (b), Arg-
Trp, Arg-Tyr (b), Arg-Val (b), Asn-Glu, Asn-Val, Asp-Ala, 
Asp-Asp, Asp-Glu, Asp-Gln, Asp-Gly, Asp-Leu, Asp-Lys, 
Asp-Phe, Asp-Trp, Asp-Val, Glu-Ala, Glu-Asp, Glu-Glu, 
Glu-Gly, Glu-Ser, Glu-Trp, Glu-Tyr, Glu-Val, Gln-Glu, 
Gln-Gln, Gln-Gly, Gly-Ala, Gly-Arg, Gly-Asn, Gly-Asp, 
α-D-glucose
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Phenotype 
MicroArrays™
Feature Substrates/agents
PM-M3 (Biolog) Energetic substrate array Carbon and energy sources/nitrogen sources (dipeptides): 
Gly-Gly, Gly-His, Gly-Ile, Gly-Leu, Gly-Lys, Gly-Met, 
Gly-Phe, Gly-Pro, Gly-Ser, Gly-Thr, Gly-Trp, Gly-Tyr, 
Gly-Val, His-Ala, His-Asp, His-Glu, His-Gly, His-His (c), 
His-Leu, His-Lys (d), His-Met, His-Pro, His-Ser, His-Trp, 
His-Tyr, His-Val, Ile-Ala, Ile-Arg (b), Ile-Asn, Ile-Gln, 
Ile-Gly, Ile-His, Ile-Ile, Ile-Leu, Ile-Met, Ile-Phe, Ile-Pro, 
Ile-Ser, Ile-Trp, Ile-Tyr, Ile-Val, Leu-Ala, Leu-Arg (b), 
Leu-Asn, Leu-Asp, Leu-Glu, Leu-Gly, Leu-His, Leu-Ile, 
Leu-Leu, Leu-Met, Leu-Phe, Leu-Pro, Leu-Ser, Leu-Trp, 
Leu-Tyr, Leu-Val, Lys-Ala (d), Lys-Arg (b), Lys-Asp, 
Lys-Glu, Lys-Gly, Lys-Ile (b), Lys-Leu (b), Lys-Lys, Lys-
Met (e), Lys-Phe, Lys-Pro, Lys-Ser, Lys-Thr, Lys-Trp (b), 
Lys-Tyr (b), Lys-Val (d), Met-Arg (b), Met-Asp, Met-Gln, 
Met-Glu, Met-Gly, Met-His, Met-Ile, Met-Leu, Met-Lys (e), 
Met-Met, Met-Phe, Met-Pro, Met-Thr, Met-Trp, Met-Tyr, 
Met-Val, Phe-Ala, Phe-Asp, Phe-Glu, α-D-glucose
PM-M4 (Biolog) Energetic substrate array Carbon and energy sources/nitrogen sources (dipeptides): 
Phe-Gly, Phe-Ile, Phe-Met, Phe-Phe, Phe-Pro, Phe-Ser, 
Phe-Trp, Phe-Tyr, Phe-Val, Pro-Ala, Pro-Arg (b), Pro-Asn, 
Pro-Asp, Pro-Glu, Pro-Gln, Pro-Gly, Pro-Hyp, Pro-Ile, 
Pro-Leu, Pro-Lys (b), Pro-Phe, Pro-Pro, Pro-Ser, Pro-Trp, 
Pro-Tyr, Pro-Val, Ser-Ala, Ser-Asn, Ser-Asp, Ser-Glu, 
Ser-Gln, Ser-Gly, Ser-His (b), Ser-Leu, Ser-Met, Ser-Phe, 
Ser-Pro, Ser-Ser, Ser-Tyr, Ser-Val, Thr-Ala, Thr-Arg (f), 
Thr-Asp, Thr-Glu, Thr-Gln, Thr-Gly, Thr-Leu, Thr-Met, 
Thr-Phe, Thr-Pro, Thr-Ser, Trp-Ala, Trp-Arg, Trp-Asp, 
Trp-Glu, Trp-Gly, Trp-Leu, Trp-Lys (e), Trp-Phe, Trp-Ser, 
Trp-Trp, Trp-Tyr, Trp-Val, Tyr-Ala, Tyr-Gln, Tyr-Glu, 
Tyr-Gly, Tyr-His, Tyr-Ile, Tyr-Leu, Tyr-Lys, Tyr-Phe, Tyr-
Trp, Tyr-Tyr, Tyr-Val, Val-Ala, Val-Arg, Val-Asn, Val-Asp, 
Val-Glu, Val-Gln, Val-Gly, Val-His, Val-Ile, Val-Leu, Val-
Lys, Val-Met, Val-Phe, Val-Pro, Val-Ser, Val-Tyr, Val-Val, 
α-D-glucose
PM-M5 (Biolog) Ions: NaCl, ammonium chloride, sodium selenite, 
potassium chloride, calcium chloride, manganese 
chloride, zinc chloride, copper (II) chloride, cobalt 
chloride, iodine, sodium phosphate, sodium 
sulphate, sodium molybdate, sodium tungstate, 
sodium orthovanadate, potassium chromate, sodium 
pyrophosphate, sodium nitrate, sodium nitrite, lithium 
chloride, ferric chloride, magnesium chloride
PM-M6 (Biolog) Hormone and metabolic effectors: dibutyryl-cAMP, 
3-isobutyl-1-methylxanthine, caffeine, epinephrine, 
norepinephrine, L-leucine, creatine, triiodothyronine, 
thyroxine, dexamethasone, hydrocortisone, progesterone, 
β-estradiol, 4,5α-dihydro-testosterone, aldosterone
PM-M7 (Biolog) Hormone and metabolic effectors: insulin, resistin, 
glucagon, ghrelin, leptin, gastrin, exendin-3, hGH 
(somatotropin), IGF-I, FGF-1 (aFGF), PDGF-AB, IL-1β, 
IL-2, IL-6, IL-8
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(HCAEC), umbilical vein (HUVEC) and normal lung fibroblasts (NHLFs) were selected for 
cellular metabolism monitoring also with the use of phenotypic assays (PM-M1 to M4). The 
results obtained in this study demonstrated that all three cell lines strongly utilised adenosine, 
inosine, D-mannose and dextrin. HCAEC also metabolised mannan, pectin, gelatine and tri-
carballylic acid, while the HUVEC cell line did not exhibit the ability to metabolise any other 
unique substrates. NHLFs were able to additionally utilise sugars and carboxylic acids [69].
Phenotype 
MicroArrays™
Feature Substrates/agents
PM-M8 (Biolog) Hormone and metabolic effectors: (Arg8) – vasopressin, 
parathyroid hormone, prolactin, calcitonin, calcitriol 
(1α,25-dihydroxyvitamin D3), luteinizing hormone 
(LH), luteinizing hormone releasing hormone 
(LH-RH), chorionic gonadotropin human (HCG), 
adrenocorticotropic hormone human (ACTH), thyrotropic 
hormone (TSH), thyrotropin releasing hormone acetate 
salt (TRH), IFN-γ, TNF-α, adenosine, Gly-His-Lys acetate 
salt
PM-M11 (Biolog) Anti-cancer agents: solasodine, rotenone, aklavine 
hydrochloride, deguelin(−), celastrol, juglone, 
sanguinarine sulphate, dactinomycin, methylmethane 
sulfonate, azathioprine, busulfan, aclarubicin, 
chloramphenicol, chloroquine diphosphate, 
cyclophosphamide, diethylcarbamazine citrate, 
emetine, fluorouracil, hydroxyurea, mechlorethamine, 
mercaptopurine, quinacrine hydrochloride, streptozosin
PM-M12 (Biolog) Anti-cancer agents: tamoxifen citrate, thioguanine, 
acriflavinium hydrochloride, pentamidine isethionate, 
mycophenolic acid, aminopterin, berberine chloride, 
emodin, puromycin hydrochloride, neriifolin, 5-fluoro-
5′-deoxyurldine, carboplatin, cisplatin, zidovudine 
(AZT), azacytidine, cycloheximide, azaserine, p-fluoro-
phenylalanine, dimethylhydrazine hydrochloride, 
phenethyl caffeate (CAPE), camptothecin, amygdalin, 
ellagic acid
PM-M13 (Biolog) Anti-cancer agents: monocrotaline, altretamine, 
carmustine, mitoxantrone hydrochloride, urethane, 
thiotepa, thiodiglycol, pipobroman, etanidazole, 
semustine, gossypol, formestane, ancitabine 
hydrochloride, nimustine, aminolevulinic acid 
hydrochloride, picropodo-phyllotoxin, beta-peltatin, 
perillyl alcohol, dibenzoylmethane, 6-amino nicotinamide, 
carmofur, indole-3-carbinol, rifaximin
PM-M14 (Biolog) Anti-cancer agents: cepharanthine, 4′-demethyl 
epipodophyllotoxin, miltefosine, elaidyl phosphocholine, 
podofilox, colchicine, methotrexate, acivicin, floxuridine, 
lefunomide, rapamycin, 13-cis retinoic acid, all-trans 
retinoic acid, piceatannol, (+)-catechin, mitomycin 
C, cytosine-beta-D-arabinofuranoside, daunorubicin 
hydrochloride, doxorubicin hydrochloride, etoposide, 
nocodazole, quercetin dihydrate, vinblastine sulphate
Table 4. Array examples [65].
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The profiling of human normal and cancer cells was also conducted by Parmar et al. [70]. 
HEK293, OV90, TOV112D, KLE, MES-SA and SKBR cell lines were selected to determine dif-
ferences in response to anti-cancer agents using PM (PM-M11 to M14) and the effect of these 
agents on the mTOR signalling pathway by measuring S6 kinase (S6K) level. From a wide 
range of anti-cancer drugs, celastrol was found to inhibit the growth of SKBR, MESA-SA and 
TOV11D and target the mTOR signalling pathway [70]. In another study, Martinez-Reyes et al. 
[71] reported that mitochondrial metabolism was necessary for histone acetylation, hypoxia-
inducible transcription factor (HIF-1) activation and proliferation based on WT-POLG and 
DN-POLG-HEK293 cell lines [71].
The application of PMs in nanotechnology is only a matter of time, thanks to the efficient 
and rapid determination of precise sites and modes of action of the tested substances. PMs 
provide a possibility to compare specificities of the study agents (e.g., drug and nanomaterial-
drug conjugates) and the effect of the agent and its side effects. Finally, the PM system can be 
used for drug interactions or drug-nanomaterial analysis [67, 72].
The limitations of large-scale phenotyping techniques, including PM analysis, are related 
to the characteristics of all cells. PMs will not reveal the phenotypes of all cells, because 
cells have many phenotypes that are dependent on their environments. Different cells are 
constantly adapting in various ways to culture (environment) changes by altering their 
gene-expression pattern, protein content, membrane and cytoskeleton constitution and 
surface receptors. Moreover, the PM system will likely not record phenotypes that specifi-
cally involve intracellular structures (e.g., cytoskeleton, organelles or surface structures). 
In addition, the effect of some genes might be cryptic and the function of those genes only 
occurs under highly specific conditions; thus, it cannot be always determined in conditions 
provided by PM cultures [73].
Another approach to phenotypic screening is focused on microarray-based three-dimensional 
(3D) systems. 3D culture models may better mimic the in vivo cellular microenvironment and 
may be critical for cell phenotypes [74]. It should also be mentioned that cell migration, com-
pound-mediated cytotoxicity, cellular adhesion, proliferation and differentiation can also be 
evaluated using non-invasive, labelled-free xCELLigence system. Electrical impedance moni-
toring is based on a set of gold microelectrodes fused to the bottom surface of a microtitre plate 
Figure 5. Schematic visualisation that highlights differences in recorded phenotypes [64].
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well. The magnitude of impedance is dependent on the number of cells, the size and shape of 
the cells and cell-substrate attachment quality; therefore, it gives the possibility to analyse the 
effect, for example, of nanomaterials on cell morphology, adhesion and biocompatibility [75].
4.2. Digital holography (DH) microscopy
Holographic (transmission) microscopy is a high-resolution imaging technique that provides 
label-free and non-invasive, non-phototoxic and non-destructive method for real-time live cell 
culture analysis [76]. This type of microscopy allows for quantitative and qualitative measure-
ments of living cells (not only cultures of mammalian cells, but also protozoan, bacterial and 
plant cells) and collecting information about cell surface area, cell viability and morphological 
changes, such as differentiation, proliferation, motility, cell death, confluence or cell segmenta-
tion (calculated from a particular hologram) [77–80]. Traditional brightfield microscopy has some 
limitations, such as difficulties in visualising individual cells due to their low contrast properties, 
whereas DH microscopy provides possibility to determine cell number directly in cell culture 
vessels [81]. The size of the HoloMonitor™ M4 (Phase Holographic Imaging AB, Lund, Sweden) 
makes it possible to place it in a cell culture incubator, so that cell observations can be conducted 
over long periods of time without any changes in cell culture conditions [78]. Digital holographic 
microscopy also enables the formation of three-dimensional (3D) images of the observed objects.
The presented technique is based on the phase shift (ϕ) of the probing laser light (or other 
coherent light source) that can be reflected or transmitted through the monitored object. The 
illuminating light is split into two beams (differing in phase): an object beam and a reference 
beam [78, 81]. The reference beam remains undisturbed, while the object beam is shifted in 
phase by the object [79]. Next, the object beam is re-joined and interferes with the reference 
beam and creates a hologram that is recorded on a digital image sensor (CCD or CMOS) 
[77, 81]. The total phase shift can be translated into optical thickness (L) and depends on the 
physical thickness of the examined object, wavelength (λ) and refraction index (n). Optical 
thickness can be measured at nanometre resolution [78, 81].
Holographic phase imaging is an excellent tool for cell morphometric characterisation and 
cell migration studies. This technique has recently been applied in clinical diagnostics, e.g., 
screening for malaria infection of erythrocytes, cancer cell analyses or sperm quality [79]. 
Interest in the use of DH microscopy in research is constantly increasing. For example, Lajkó 
et al. [82] analysed the effect of a drug based on GnRH-III (gonadotropin-releasing hormone-
III) on melanoma cells. Holographic phase imaging was used to visualise the migratory 
behaviour of melanoma cells in response to daunorubicin (Dau) coupled with GnRH-III and 
its derivatives (modified at position 4 with Lys(Ac) (conj1) or Lys(nBu) (conj2)). Cell migra-
tion analysis showed increased migration activity when cells were exposed to conj1, whereas 
conj2 decreased melanoma cell activity and exerted an immobilising effect on tumour cell 
spreading; thus, it was a better candidate for targeted tumour therapy [82]. Monitoring of 
HeLa cancer cells and MC3T3-E1 preosteoblast cells via holographic technique was also 
conducted by Peter et al. [78]. These authors evaluated cell movements and morphological 
parameters of cells in two experiments. In the first one, the HoloMonitor™ M4 was used to 
detect the effect of EGCg (green tea—epigallocatechin gallate) on HeLa cell motility. Time-lap 
images showed that migration, motility and the speed of motility were reduced after EGCg 
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was added to the culture. The second experiment involved MC3T3 plated on transparent 
titanate nanotubes (TNT) surface and the impact on adhesion and spreading process of the 
cells was demonstrated using the HoloMonitor. The authors have concluded that holographic 
digital microscopy is a useful tool for cellular behaviour analysis, but some limitations have 
also been found. Peter et al. [78] observed that under certain thicknesses, some parts of the 
cells (e.g., parts of the thin lamellipodium) slicked into the background surface. It was caused 
by the limited vertical resolution of the optical system [78].
In our study, the effect of the h-BN-Au nanocomposite on L929 and MCF-7 cell lines was 
analysed during 12-h incubation using the HoloMonitor™ M4. L929 cells did not show any 
significant differences in the presence of the nanocomposite and the doubling time (DT) value 
was similar to DT obtained in the control culture (Figure 6). The results obtained for the 
MCF-7 cell line incubated with h-BN-Au demonstrated a stronger effect on cells. The DT 
analysis using holographic technique indicated a high reduction of proliferation capacity (the 
DT value for the MCF-7 control sample was 25.95 h, whereas for experimental cultures, it was 
469.9 h) [83].
Figure 6. The morphology of the L929 and MCF-7 cell lines incubated with the h-BN-Au nanoparticles. L929 culture 
time-points at 0 h (A); at 12 h (B); MCF-7 culture time-points at 0 h (C); at 12 h (D) [83].
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4.3. Atomic force microscopy (AFM)
Atomic force microscopy (AFM) is based on a laser reflected off a cantilever onto a scanning 
surface of the examined object and quantitative information about surface morphology and 
cell spread is collected.
AFM is a crucial technique for determining cell interactions on the surface of the tested material. 
If material exhibits high biocompatibility, the surface of the material will allow cells to attach 
(interaction between cell-surface integrin receptors) and adsorb extracellular matrix (ECM) 
proteins. Surface properties, such as wettability, roughness or surface charge, are important 
for cellular attachment and lamellipodium/filopodium formation. The AFM measurement 
provides information on cellular morphology changes and lamellipodium/filopodium per-
missiveness. The measurement of atomic force microscopy of living cells can be performed 
in PBS and provides information on cell height, total cell surface area, attachment angle and 
extension of lamellipodia/filopodia. It is also possible to measure fixed cell (in 4% paraformal-
dehyde) topography and examine filopodia and lamellipodia. An interesting example is the 
analysis of H4 and PC12 cell lines plated on different materials—glass, polystyrene (PSt), sili-
con (Si), nanocrystalline diamond (NCD) and cubic silicon carbide (3C-SiC). In the latter study, 
AFM analysis demonstrated that the type of the surface determined cell height/area, attach-
ment angle and the reduction of the lamellipodium/filopodium area. Cell-substrate interac-
tion was different for H4 and PC12 cell lines, e.g., for H4 cells; the most negative interaction 
was recorded for glass, the most positive for 3C-SiC, while PC12 cells had the most negative 
interaction with glass, but the best with 3C-SiC and PSt. The authors concluded that AFM 
analysis indicated that neural cell interactions with 3C-SiC resulted in the optimal cell viabil-
ity, morphology and interaction of cells with 3C-SiC surface [1]. Frewin et al. [1] published the 
results of AFM analysis concerning cellular interaction on graphene. The experiments focused 
on cytoskeleton organisation and the determination of the number of contact sites, and AFM 
technology can provide valuable information on the mechanism of cellular adhesion and 
proliferation on graphene surface. Different methods of graphene preparation, for example, 
mechanical cleaving, chemical synthesis and chemical vapour deposition (CVD) on metals or 
epitaxial growth on SiC, not only give graphene different electrical, optical or morphological 
properties, but also different biocompatibility. For example, the biocompatibility of a single 
graphene layer produced by CVD on Cu was higher in comparison with SiO
2
/Si surfaces stud-
ied on human osteoblasts and mesenchymal stem cells [1, 84]. In another study, epitaxially 
grown graphene films on (0001) 6H-SiC substrates were evaluated in cellular response experi-
ments using AMF analysis. It was found that HaCaT (human keratinocytes) after 72-h culture 
on graphene and 6H-SiC surfaces exhibited similar morphology to cells cultured on the PSt 
control. On the other hand, the MTT assay suggested better biocompatibility for 6H-SiC than 
for the graphene surface. Moreover, different preparation of graphene surfaces (first one with-
out any further surface treatment, and the second one additionally disinfected by immersion 
in ethanol) resulted in more homogeneous and increased cell adhesion on ethanol-sterilised 
graphene surface [1]. Our study also confirmed the undeniable value of AMF analysis in the 
experiment involving the MAC-T cell line seeded on different surfaces (glass, glass coated 
with poly-D-lysine) (Figure 7). In the aforementioned study, surface analysis and cell height 
analysis clearly exhibited differences in cell growth on the two surface variants [85].
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Another notable study used the AFM technique not only for cell analysis after nanoparticle 
uptake, but also after exposure to rotating magnetic field (RMF). Observations of MCF-7 cells 
after 1.5-h incubation in 40 mT magnetic field revealed changes in cell surface, which was 
rougher with many small pore-like structures in comparison to untreated cells [86].
5. Conclusions
The present overview describes and compares widely used biocompatibility/cytotoxicity 
assays in nanomaterial studies. Due to the type of nanoparticles and their properties, appli-
cability of popular assays used for engineered nanomaterial screening might be limited. The 
significant numbers of false-positive or false-negative signals are generated [16]. The tendency 
of nanoparticles to:
Figure 7. AFM analysis of MAC-T cells: cell height on glass surface (A); cell height on glass coated with poly-D-lysine (B); 
3D image of cell growing on glass surface (C); 3D image of cell growing on poly-D-lysine (D) [85].
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• Interact and photocatalyse assay reagents,
• Create agglomerate in the conditions of in vitro and in vivo environment,
• Create protein layer of several nanometres on nanoparticle surface,
• Degrade and deform in vitro environment,
affect the results obtained in popular assays, thus classic cytotoxicity assays alone are not suf-
ficient to evaluate nanomaterial biocompatibility.
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